Global Cancer Supportive Care Medicine Market Survey and Trend Research 2018

June 2018 | 75 pages | ID: GFD84B61647EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Amgen, Helsinn Healthcare, Johnson &Johnson, Merck, GlaxoSmithKline, GlaxoSmithKline, Heron Therapeutics, Kyowa Hakko Kirin, Novartis, TESARO, Teva Pharmaceutical Industries etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Cancer Supportive Care Medicine Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 CANCER SUPPORTIVE CARE MEDICINE MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Amgen (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Helsinn Healthcare (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Johnson &Johnson (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Merck (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 GlaxoSmithKline (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 GlaxoSmithKline (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Heron Therapeutics (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Kyowa Hakko Kirin (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Novartis (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 TESARO (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Teva Pharmaceutical Industries (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Cancer Supportive Care Medicine Market 2012-2017, by Type, in USD Million
Table Global Cancer Supportive Care Medicine Market 2012-2017, by Type, in Volume
Table Global Cancer Supportive Care Medicine Market Forecast 2018-2023, by Type, in USD Million
Table Global Cancer Supportive Care Medicine Market Forecast 2018-2023, by Type, in Volume
Table Amgen Overview List
Table Cancer Supportive Care Medicine Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Helsinn Healthcare Overview List
Table Cancer Supportive Care Medicine Business Operation of Helsinn Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson &Johnson Overview List
Table Cancer Supportive Care Medicine Business Operation of Johnson &Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Cancer Supportive Care Medicine Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Cancer Supportive Care Medicine Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Cancer Supportive Care Medicine Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Heron Therapeutics Overview List
Table Cancer Supportive Care Medicine Business Operation of Heron Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Overview List
Table Cancer Supportive Care Medicine Business Operation of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Cancer Supportive Care Medicine Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TESARO Overview List
Table Cancer Supportive Care Medicine Business Operation of TESARO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Overview List
Table Cancer Supportive Care Medicine Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Cancer Supportive Care Medicine Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Cancer Supportive Care Medicine Sales Revenue Share, by Companies, in USD Million
Table Global Cancer Supportive Care Medicine Sales Volume 2012-2017, by Companies, in Volume
Table Global Cancer Supportive Care Medicine Sales Revenue Share, by Companies in 2017, in Volume
Table Cancer Supportive Care Medicine Demand 2012-2017, by Application, in USD Million
Table Cancer Supportive Care Medicine Demand 2012-2017, by Application, in Volume
Table Cancer Supportive Care Medicine Demand Forecast 2018-2023, by Application, in USD Million
Table Cancer Supportive Care Medicine Demand Forecast 2018-2023, by Application, in Volume
Table Global Cancer Supportive Care Medicine Market 2012-2017, by Region, in USD Million
Table Global Cancer Supportive Care Medicine Market 2012-2017, by Region, in Volume
Table Cancer Supportive Care Medicine Market Forecast 2018-2023, by Region, in USD Million
Table Cancer Supportive Care Medicine Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Cancer Supportive Care Medicine Industry Chain Structure
Figure Global Cancer Supportive Care Medicine Market Growth 2012-2017, by Type, in USD Million
Figure Global Cancer Supportive Care Medicine Market Growth 2012-2017, by Type, in Volume
Figure Global Cancer Supportive Care Medicine Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Cancer Supportive Care Medicine Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region